Wells Fargo’s CONMED CNMD Stock Holding History

Wells Fargo’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-15,700	Closed	-$1.09M	–	6938
2024 Q2	$1.09M	Buy	+15,700	New	+$1.15M	﹤0.01%	3433
2023 Q2	–	Sell	-60,000	Closed	-$6.23M	–	7602
2023 Q1	$6.23M	Sell	60,000 -6,000	-9%	-$580K	﹤0.01%	1953
2022 Q4	$5.85M	Buy	+66,000	New	+$5.48M	﹤0.01%	1962

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Wells Fargo's CNMD Position: Q2 2026 in Review

Wells Fargo increased its CONMED (CNMD) stake by 19% in Q2 2026, buying an estimated $673K and bringing the position to 115,059 shares worth $3.77M. The position accounts for ﹤0.01% of the portfolio, ranked #3100.

Wells Fargo first reported a position in CNMD in Q2 2013 and has held it in 53 quarters since. The position peaked at $85.6M in Q2 2023. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

Wells Fargo held 115,059 shares of CONMED worth $3.77M as of Q2 2026.
Wells Fargo bought 18,690 CONMED shares in Q2 2026, an estimated $673K.
CONMED made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #3100 holding.
Wells Fargo first reported a position in CONMED in Q2 2013 and has held it in 53 quarters since.
Wells Fargo's CONMED position peaked at $85.6M in Q2 2023.
246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.